Spotlight on ERINHA-Advance member, National Institute of Infectious Diseases (INMI) of Italy involved in CONVAT project. CONVAT consortium got funding from the European Commission emergency call. It is a cooperation project between Spain, Italy and France to develop a point-of-care platform, for rapid diagnosis and monitoring of coronavirus, directly from the patient’s sample and without […]

ERINHA is involved in EUROCOVID project consortium recently submitted to IMI call “Development of therapeutics and diagnostics combatting coronavirus infections”. EUROCOVID EUROpean COoperation for anti-VIral Drug discovery and preparedness for current and emerging coronavirus outbreaks”creates a European, multidisciplinary world-class network for the development of pan-coronavirus antivirals that will rapidly respond to the current SARS-CoV 2 outbreak […]

ERINHA welcomes its newest Member: The Rega Institute for Medical Research of the Katholieke Universiteit Leuven (KU Leuven), Belgium The Rega Institute for Medical Research of KU Leuven joined ERINHA infrastructure in February 2020. The institute has a long-standing experience and expertise in the discovery and development of antiviral drugs. Notably, in collaboration with the […]

“Rapid therapy development through Open Coronavirus Vaccine Platform” – Spotlight on ERINHA Swedish node research activities OPENCORONA consortium has been awarded €3m funding by the European Commission Horizon 2020 emergency call to support research and development against the COVID-19 outbreak, aiming to develop a vaccine for the novel virus. The Consortium is led by Karolinska Institute, […]

CORBEL: A new website, lifescience-ri.eu, brings together the vast services of 13 Life Science Research Infrastructures.This website aims to be a common source of comprehensive information about the 13 European LS RIs, their activities, offers, news and funding opportunities. Their joint service catalogue allows to identify which RI might be able to meet a certain need. […]

ERINHA national node, INSERM’s BSL4 Laboratory Jean Mérieux provided a talk on Nipah virus research at the First REACTing Symposium on Emerging Infectious Diseases, held on November 21, 2019 at the Insitut Pasteur in Paris. REACTing (REsearch and ACTion targeting emerging infectious diseases) is a collaborative network of major French research institutions, coordinated by INSERM, […]

The joint EDCTP and CEPI call on “Vaccines against Lassa virus disease” was launched to support distinct strategic actions (clinical research activities) which are part of efforts to prepare and conduct a large-scale clinical trial. The goal is to achieve proof of concept and/or demonstrate the efficacy of novel candidate vaccines against Lassa virus (LASV). […]

First TransNational Access Call to ERINHA’s full catalogue of services, including access to cutting edge high containment facilities was launched today! The call is funded under the EU H2020 ERINHA-Advance project. The following pathogens are prioritized: Ebola virus Marburg virus Lassa virus Crimean Congo Hemorrhagic Fever virus Nipah virus Applications must fall into one of […]

ERINHA provided a talk at the 2 nd CORBEL Service Operator and User Meeting held on 1-2 October, 2019 at the EMBL in Heidelberg. The meeting brought together European scientists who have been supported by CORBEL project and the research infrastructures’ (RI) service operators. The meeting aimed to facilitate interactions among users and service providers, […]

A Memorandum of Understanding was signed on September 19, 2019 between ERINHA AISBL and European Vaccine Initiative, coordinator of TRANSVAC2 project.TRANSVAC2 (the European Network of Vaccine Research and Development) supports innovation for both prophylactic and therapeutic vaccine development and aims to establish a sustainable vaccine development infrastructure in Europe. By signing the MoU, EVI and ERINHA intend […]